The anticoagulant market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses that the market is growing with a CAGR of 5.1% in the forecast period of 2020 to 2027 and is expected to reach USD 82.01 million by 2027. The rising prevalence of venous thromboembolism and pulmonary embolism and a growing number of surgeries are the major drivers which propelled the demand of the market in the forecast period.
Download Sample PDF Copy of this Report to understand the structure of the complete report (Including Full TOC, Table Figures) https://www.databridgemarketresearch.com/request-a-sample/?dbmr=south-africa-anticoagulant-market
Market Overview
The anticoagulant market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to anticoagulant market.
Key players operating in the global South Africa Anticoagulant market include:
- Sanofi,
- Fresenius Kabi AG (A subsidiary of Fresenius SE Co KGaA)
- Aspen Holdings
- Cipla Inc
- Bayer AG
- Pfizer Inc.
- Boehringer Ingelheim International GmbH
- Adcock IngramThe Global Anticoagulant market is segmented on the basis of drug class, therapeutic areas, route of administration, end-user, and distribution channel. The growth among segments helps you to analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.
- On the basis of drug class, the anticoagulant market is segmented into vitamin K antagonists (Warfarin), non-VKa oral anticoagulants (NOACs), heparin LMWH, thrombin inhibitors (Dabigatran). The vitamin K antagonist segment is expected to dominate the market as warfarin is the most preferred anticoagulant in South Africa. As warfarin is cost-effective is mostly preferred over other anticoagulants in South Africa.
- On the basis of therapeutic areas, the anticoagulant market is segmented into deep vein thrombosis (DVT), pulmonary embolism (PE), atrial fibrillation, heart attack, stroke, unstable angina, hip or knee replacement surgery, and others. The deep vein thrombosis segment is expected to dominate the market due to its increasing prevalence of it which led to mortality and morbidity in South Africa.
- On the basis of the route of administration, the anticoagulant market is segmented into oral and parenteral. The oral segment is expected to dominate the market due to the increasing demand of vitamin K antagonist which is mostly administered in oral form.
- On the basis of end-user, the anticoagulant market is segmented into hospitals, clinics, home healthcare ambulatory surgical centers, and others. The hospital segment is expected to dominate the market as hospitals are the first point of contact for cardiovascular surgery treatments and procedures.
- On the basis of distribution channels, the anticoagulant market is segmented into hospitals pharmacy, retail pharmacies, online pharmacies, and others. The hospital pharmacy segment is expected to dominate the market as most of the patients visit the hospital’s emergency room for treatment of severe cardiovascular disease, and cancer among others, and hence they used to buy medicine from hospital pharmacies.Browse More About This Research Report @ https://www.databridgemarketresearch.com/reports/south-africa-anticoagulant-marketTable of Content:
Global Medical Robotic System Market Scope
Chapter 1: Market Overview
Chapter 2: South Africa Anticoagulant Market
Chapter 3: Regional Analysis of the South African Anticoagulant market industry
Chapter 4: Regional Analysis of the South African Anticoagulant Market on types and Applications
Chapter 5: Revenue analysis based on types and Applications
Chapter 6: Market share
Chapter 7: Competitive Landscape
Chapter 8: Drivers, Restraints, Challenges, and Opportunities
Chapter 9: Gross Margin and Price Analysis
Get the Full Table of Contents @ https://www.databridgemarketresearch.com/toc/?dbmr=south-africa-anticoagulant-market
Browse Trending Reports:
About Data Bridge Market Research:
An absolute way to predict the future is to understand the current trend! Data Bridge Market Research presented itself as an unconventional and neoteric market research and consulting firm with unparalleled resilience and integrated approaches. We are committed to uncovering the best market opportunities and nurturing effective information for your business to thrive in the marketplace. Data Bridge strives to provide appropriate solutions to complex business challenges and initiates an effortless decision-making process. Data Bridge is a set of pure wisdom and experience that was formulated and framed in 2015 in Pune.
Data Bridge Market Research has more than 500 analysts working in different industries. We have served more than 40% of the Fortune 500 companies globally and have a network of more than 5,000 clients worldwide. Data Bridge is an expert in creating satisfied customers who trust our services and trust our hard work with certainty. We are pleased with our glorious 99.9% customer satisfaction rating.
Contact Us: -
Data Bridge Market Research
US: +1 888 387 2818
United Kingdom: +44 208 089 1725
Hong Kong: +852 8192 7475
